Ndugga-Kabuye et al (2019)44 found that African-American patients with cancer who were offered genetic testing for the BRCA1/2 and HNPCC genes were more likely than their NHW counterparts to be identified as having a VUS (18.8% vs 6.1%; P < .001). Here, BRCA1 is linked to cancer.